The hemostats and tissue sealants market share will post an incremental growth of USD 2.24 billion, progressing at a CAGR of 9.82% during the forecast period. The use of hemostats and tissue sealants in surgeries will offer immense growth opportunities to market vendors. The hemostats and tissue sealants market is fragmented, and the vendors are deploying growth strategies such as low-pricing strategies and strengthening the local customer base to compete in the market.
Technavio’s report on “Hemostats and Tissue Sealants Market by Product and Geography - Forecast and Analysis 2022-2026” provides a detailed analysis of the prevalent market forces, trends, and challenges likely to impact the market in focus.
The hemostats and tissue sealants market is segmented by product (hemostats, tissue sealants and adhesives, and fibrin sealants) and geography (Europe, APAC, North America, South America, and Middle East and Africa).
The growth of the hemostats and tissue sealants market size in the hemostats segment will be significant during the forecast period. The growth of the segment will be attributed to the factors such as increasing demand for hemostats in surgical procedures and the growing awareness of the clinical benefits of hemostats.
By geography, factors such as the availability of advanced healthcare infrastructure and the rising number of surgical procedures will facilitate the hemostats and tissue sealants market growth in North America. 46% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for hemostats and tissue sealants in North America.
The use of hemostats and tissue sealants in surgeries will directly influence the sales of hemostats and tissue sealants market. In addition, the increasing R&D focus on novel hemostats and tissue sealants are the major hemostats and tissue sealants market trends that will positively impact the market growth. However, factors such as the high cost of hemostats and tissue sealants will hamper the hemostats and tissue sealants market growth.
The market is fragmented due to the presence of several players. Some of the major hemostats and tissue sealants market vendors are Advanced Medical Solutions Group Plc, Artivion Inc., B. Braun SE, Baxter International Inc., Becton Dickinson and Co., BioCer Entwicklungs GmbH, Biomup SA, Cardinal Health Inc., CSL Ltd., Hemostasis LLC, Integra Lifesciences Holdings Corp., Johnson and Johnson, KATSAN KATGUT SANAYI VE TICARET A.S, Medtronic Plc, Pfizer Inc., Stryker Corp., Teijin Ltd., Teleflex Inc., Tricol Biomedical Inc., and Vivostat AS
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
Download the Free PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2022-2026.
CAGR of the hemostats and tissue sealants market forecast during 2022-2026.
Market-level data on units, average selling prices, and values of the hemostats and tissue sealants market share.
Prediction on the upcoming trends, drivers, and factors that challenge the growth of the hemostats and tissue sealants market.
hemostats and tissue sealants industry growth across Europe, APAC, North America, South America, and Middle East and Africa.
